CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis

CXCL16/CXCR6 及其在自身免疫性关节炎中的作用

基本信息

  • 批准号:
    8132742
  • 负责人:
  • 金额:
    $ 10.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-13 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

The etiology and pathogenesis of rheumatoid arthritis (RA) remain obscure despite intense investigation. Chemokines play a critical role in attracting and retaining leukocytes in the inflamed joints. However, the precise mechanism for cell positioning in the joints is unclear. The long-term goal of this project is to understand the mechanism of cell trafficking and inflammatory responses in nonlymphoid tissues in the settings of autoimmune diseases. Recently we have found that CXCL16, a newly identified chemokine, and its receptor, CXCR6, are highly expressed in the joints of mice with collagen-induced arthritis (CIA), an animal model of RA. CXCL16 is the second member of the chemokine family with a transmembrane domain. The receptor-bearing cells are mainly Th1 cells, display extralymphoid tissue homing potential and are enriched in inflamed synovial fluid of RA patients. Treatment of mice with CXCL16-lg fusion protein significantly ameliorates CIA. Thus, we hypothesize that CXCL16/CXCR6 play an important role in the pathogenesis of autoimmune arthritis. This project will focus on the mechanisms that regulate CXCL16/CXCR6 expression and the contribution of CXCL16/CXCR6 to the initiation and progression of CIA. Chemokines that are preferentially expressed in Th1-mediated inflammatory disorders like RA, such as CXCR3 and CCR5, will also be investigated during the course of CIA as comparative studies to further elucidate the role of CXCL16/CXCR6 in the pathogenesis of CIA. In addition, we hypothesize that CXCL16/CXCR6 may mediate interactions among T cell, B cells, macrophages and other cells in the affected sites because of the unique structure CXCL16 as a membrane chemokine and its expression pattern. The role of CXCL16/CXCR6 in mediating T cell-antigen presenting cells will be studied. Aside from enhancing our understanding of leukocyte migration in rheumatoid joints, these studies are expected to provide important information regarding chemokine functions in regulating activation and differentiation of lymphocytes and macrophages during inflammatory responses. The study will also provide insights into new targets for designing anti-inflammatory agents in autoimmune arthritis and other autoimmune diseases
类风湿性关节炎(RA)的病因和发病机制仍不清楚,尽管强烈的 调查趋化因子在吸引和保留炎症关节中的白细胞方面起着关键作用。然而,细胞在关节中定位的精确机制尚不清楚。 本研究的长期目标是了解自身免疫性疾病背景下非淋巴组织中细胞运输和炎症反应的机制。最近我们发现,CXCL 16,一个新发现的趋化因子,及其受体,CXCR 6,高表达在小鼠关节胶原诱导关节炎(CIA),一种动物模型的RA。CXCL 16是具有跨膜结构域的趋化因子家族的第二个成员。受体携带细胞主要是Th 1细胞,显示淋巴外组织归巢潜力,并在RA患者的炎症滑液中富集。用CXCL 16-Ig融合蛋白治疗小鼠显著改善CIA。因此,我们推测CXCL 16/CXCR 6在自身免疫性关节炎的发病机制中起重要作用。该项目将重点关注调节CXCL 16/CXCR 6表达的机制,以及CXCL 16/CXCR 6对 中情局的成立和发展在CIA过程中还将研究优先在Th 1介导的炎性疾病如RA中表达的趋化因子,如CXCR 3和CCR 5,作为比较研究,以进一步阐明CXCL 16/CXCR 6在CIA发病机制中的作用。另外,我们推测CXCL 16/CXCR 6可能介导T细胞、B细胞、巨噬细胞和其他细胞之间的相互作用,这是由于CXCL 16作为一种膜趋化因子的独特结构及其表达模式。将研究CXCL 16/CXCR 6在介导T细胞-抗原呈递细胞中的作用。除了增强我们对类风湿关节中白细胞迁移的理解外,这些研究还有望提供有关趋化因子在调节关节炎中的功能的重要信息。 炎症反应期间淋巴细胞和巨噬细胞的活化和分化。该研究还将为设计自身免疫性关节炎和其他自身免疫性疾病的抗炎剂提供新的靶点

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHUHUA HAN其他文献

SHUHUA HAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHUHUA HAN', 18)}}的其他基金

CXCL16 as a therapeutic target for atherosclerosis
CXCL16作为动脉粥样硬化的治疗靶点
  • 批准号:
    7876814
  • 财政年份:
    2009
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16 as a therapeutic target for atherosclerosis
CXCL16作为动脉粥样硬化的治疗靶点
  • 批准号:
    7744566
  • 财政年份:
    2009
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    7451534
  • 财政年份:
    2007
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    7335584
  • 财政年份:
    2005
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    7161337
  • 财政年份:
    2005
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    7030944
  • 财政年份:
    2005
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    6920904
  • 财政年份:
    2005
  • 资助金额:
    $ 10.23万
  • 项目类别:
CXCL 16/CXCR6 and Their Roles in Autoimmune Arthritis
CXCL 16/CXCR6 及其在自身免疫性关节炎中的作用
  • 批准号:
    6775372
  • 财政年份:
    2004
  • 资助金额:
    $ 10.23万
  • 项目类别:
Regulation of the B-Cell Development and Differentiation
B 细胞发育和分化的调节
  • 批准号:
    6760098
  • 财政年份:
    2003
  • 资助金额:
    $ 10.23万
  • 项目类别:
Regulation of the B-Cell Development and Differentiation
B 细胞发育和分化的调节
  • 批准号:
    6682636
  • 财政年份:
    2003
  • 资助金额:
    $ 10.23万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了